In comparison, in the field of cancer medicine, it is recognized that following repeated and chronic periods of hypoxia, selection for resistance to the hypoxia-induced HIF1 response may occur, which exacerbates hypoxia-adaptive pathologies (Greijer and van der Wall, 2004). Here, HIF1A is linked to cancer.